Menu

MassHealth, the Massachusetts Medicaid program, will soon bar managed care plans for paying for certain high-cost obesity drugs using 340B.

Massachusetts to Bar Managed Medicaid Payments for GLP-1 Drugs for 340B Patients

March 7, 2024 Rich Daly Editor in Chief Views

Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly